Stockscreener 앱 받기
1.73
11.73%
-0.23
Pacific Biosciences Of California Inc 주식(PACB)의 최신 뉴스
Pacific Biosciences of California, Inc. (PACB) Latest Stock News & HeadlinesYahoo Finance - Yahoo! Finance Canada
Pacific Biosciences of California (PACB) Declines More Than Market: Some Information for Investors - Yahoo! Finance Canada
Pacific Biosciences of California (PACB) Declines More Than Market: Some Information for Investors - Zacks Investment Research
PacBio to Report Third Quarter 2026 Financial Results on November 4, 2026 - GlobeNewswire
PacBio Teams With TychoBio to Advance AI-Driven RNA Therapeutics - TradingView
PacBio Teams With TychoBio to Advance AI-Driven RNA Therapeutics - Zacks Investment Research
PACB5949325 Bond Profile: Coupon and Redemption - TradingView
Weekly Recap: PACB Q2 results, narrowed guidance and TychoBio RNA AI - TradingView
Form 144 Pacific Biosciences of California For: 11 October By Investing.com - Investing.com South Africa
Pacific Biosciences CFO reports $2.05m stock sale - Investing.com
Form 4 Pacific Biosciences of California For: 10 October By Investing.com - Investing.com Nigeria
PacBio (PACB) Stock Gets Fair Value Boost After UBS Starts Coverage Neutral - Yahoo Finance
Why Pacific Biosciences of California (PACB) Dipped More Than Broader Market Today - Yahoo Finance UK
Why Pacific Biosciences of California (PACB) Dipped More Than Broader Market Today - Zacks Investment Research
Why Pacific Biosciences of California (PACB) Dipped More Than Broader Market Today - Yahoo Finance
Pacific Biosciences of California Insider Sold Shares Worth $2,056,921, According to a Recent SEC Filing - www.marketscreener.com
PACB Slides As UBS Starts Coverage With Neutral Target - StocksToTrade
Harnessing the Kivvi tool to resolve the genetics of FSHD with HiFi sequencing - PacBio
Pacific Biosciences of California (PACB) Institutional Ownership 2026 - MarketBeat
Barclays Maintains Pacific Biosciences of California(PACB.US) With Sell Rating, Maintains Target Price $1.25 - Moomoo
Pacific Biosciences of California (NasdaqGS:PACB) Stock Forecast & Analyst Predictions - Simply Wall Street
500,000 option-exercise shares are part of an officer's planned sale at Pacific Biosciences (PACB). - Stock Titan
PACB Stock Slides As UBS Starts Coverage With Neutral Call - StocksToTrade
PacBio Slides as Recent Rally Cools and Investors Reassess Turnaround Risks - Quiver Quantitative
PacBio Sinks 8% as TychoBio Endorses Its “Highest Quality Biological Data” – the Real Story Is More Complicated - Yahoo Finance
PacBio Deepens AI Drug-Discovery Push With TychoBio Deal — PACB Stock Takes A Breather After 103% Rally - Yahoo Finance
PacBio (PACB) Partners with TychoBio to Advance RNA Therapy Deve - GuruFocus
Apogee Enterprises Posts Upbeat Q2 Earnings, Joins Constellation Energy, Freshworks And Other Big Stocks - Benzinga
Pacific Biosciences of California, TychoBio Collaborate to Generate Full-Length RNA Data for AI Model Training - Yahoo Finance
Pacific Biosciences of California, Inc. (PACB) stock price, news, quote and history - Yahoo Finance Singapore
PacBio and TychoBio Collaborate to Train AI Models for Rare Disease RNA Therapeutics - marketscreener.com
PacBio and TychoBio Collaborate to Train AI Models for Rare Disease RNA Therapeutics - GlobeNewswire
Why PacBio (PACB) Stock Is Trading Up Today - Yahoo Finance
Why PacBio (PACB) Stock Is Trading Up Today - StockStory
Why PacBio (PACB) Stock Is Trading Up Today - The Globe and Mail
Immunogenomics Market Size, Share, Trends, and Growth Forecast, 2026-2033 | NGS and Personalized Medicine Drive Market Toward USD 9.82 Billion at 5.97% CAGR - GlobeNewswire Inc.
PACB5630687 Bond Profile: Coupon and Redemption - TradingView
Pacific Biosciences of California (PACB) Rises Higher Than Market: Key Facts - Yahoo Finance
Pacific Biosciences of California (PACB) Rises Higher Than Market: Key Facts - Zacks Investment Research
Pacific Biosciences of California Company Profile & Introduction - Moomoo
PACB Stock Climbs As Traders Eye Conference Catalyst - StocksToTrade
3 Biotech Stocks Put Traders Are Targeting Today - Yahoo Finance
Powered by PacBio: Selected publications from July – September 2026 - PacBio
Pacific Biosciences: Stock Surges As New Use Case SeenBut Caution Is Warranted (PACB) - Seeking Alpha
Why Is PacBio (PACB) Stock Soaring Today - Yahoo Finance
Pacific Biosciences Up Over 30%, On Pace for Largest Percent Increase Since July 2024 -- Data Talk - Moomoo
Why Is PacBio (PACB) Stock Soaring Today - TradingView
PACB Stock Grinds Higher As Traders Eye Morgan Stanley Chat - timothysykes.com
PACB Stock Grinds Higher As Traders Eye Morgan Stanley Chat - StocksToTrade
Stocks making big moves yesterday: TTM Technologies, PacBio, Nvidia, Palo Alto Networks, and Teleflex - Yahoo Finance
3.31%
자본화:
|
볼륨(24시간):